Commission inks deal for COVID-19 treatment remdesivir

The European Commission signed a contract with U.S. drugmaker Gilead for remdesivir, an antiviral drug shown to be effective in treating cases of COVID-19, providing enough doses for 30,000 patients, according to a press release Wednesday. Starting in August, the medicine will be available to both…